Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgae155 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Laís de Castro Carvalho Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Parasitologia e Patologia, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Praziquantel, Schistosomiasis, Nanostructures, Schistosomicides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Brazilian agencies: Fundação do Amparo à Pesquisa do Estado de Minas Gerais, Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil.
Abstract (Originalsprache)
Background
Schistosomiasis is a neglected tropical disease caused by Schistosoma sp., and praziquantel (PZQ) is the first-line treatment. However, traditional PZQ formulations have low solubility and fast metabolism, limiting its effectiveness. Thus, nanoparticles have been proposed to improve the bioavailability and efficacy of poorly soluble antischistosomal drugs.
Aims
This systematic review used in vivo preclinical studies to map the available evidence and compare the efficacy of free PZQ and PZQ-based nanostructured formulations (N-PZQ) for schistosomiasis treatment.
Methods
PubMed, Embase, Scopus, and Web of Science were searched, and 1186 experimental studies published between 1974 and 2024 were screened. Parasitological, histopathological, pharmacokinetic, and toxicological outcomes were evaluated.
Results
Twelve relevant studies were identified exploring N-PZQ formulations based on liposomes, nanoliposomes, and nanocrystals. N-PZQ demonstrated better therapeutic efficacy than free PZQ, reducing parasite load, modifying oogram profiles, and down-regulating liver granuloma development (number and size). N-PZQ also exhibited improved pharmacokinetic profile, with enhanced bioavailability and longer half-life, as well as reduced toxicity (cytotoxicity, genotoxicity, and hepatotoxicity) compared to free PZQ.
Conclusion
PZQ-based nanostructured formulations represent a promising strategy to enhance schistosomiasis treatment by improving chemotherapy efficacy, optimizing antiparasitic responses, pharmacokinetics, and reducing drug toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Parasitologia e Patologia, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.
- Departamento de Biologia Estrutural, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.
- Departamento de Microbiologia e Imunologia, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.
- Departamento de Alimentos e Medicamentos Faculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, 37130-001, Minas Gerais, Brazil.
ORCID-Profile: Laís de Castro Carvalho Silva, Marcos José Marques
Förderung
- Brazilian agencies: Fundação do Amparo à Pesquisa do Estado de Minas Gerais
- Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil
Zitieren
APA
de Castro Carvalho Silva, L., Cunha Dos Reis, L. F., Malaquias, L. C. C., Carvalho, F. C., Novaes, R. D., & Marques, M. J. (2025). Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae155
Vancouver
de Castro Carvalho Silva L, Cunha Dos Reis LF, Malaquias LCC, Carvalho FC, Novaes RD, Marques MJ. Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae155
BibTeX
@article{deCastroCarvalhoSilva2025,
author = {de Castro Carvalho Silva, Laís and Cunha Dos Reis, Luís Felipe and Malaquias, Luiz Cosme Cotta and Carvalho, Flávia Chiva and Novaes, Rômulo Dias and Marques, Marcos José},
title = {Impact of nanostructured formulations for schistosomiasis treatment: a systematic review of in vivo preclinical evidence},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgae155}
}
EUVIMED